The Patent Finder

Universite Paris Descartes

10 patents currently held · Updated Nov 21, 2026
173 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 8 name spellings.

3
Ending by 2030
Dec 2028
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Jun 1, 2027
    The maintenance fee for Method and Pharmaceutical Composition for Use in the Treatment of Cancer (US 9,198,949) comes due Jun 1, 2027. Unpaid by Dec 1, 2027, it lapses early.
  • 2 fees due Sep 19 to 22, 2027 · next Sep 19

Which patents, and when each one lapses · Pro

Recent changes

  • 5 terms have ended since Aug 23, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 10 of 10

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 11,931,411Allergen Desensitization Method
In force
 · High confidence
In forceHigh confidence
US 9,867,971Device for Administering Cells and Cell-Therapy Methods Using Said Device
In force
 · High confidence
In forceHigh confidence
US 8,815,239GLYCOCONJUGATES AND USE THEREOF AS VACCINE AGAINST SHIGELLA FLEXNERI SEROTYPE 3a AND X
In force
 · High confidence
In forceHigh confidence
US 9,931,341Antagonist of the Fibroblast Growth Factor Receptor 3 (FGFR3) for Use in the Treatment or the Prevention of Skeletal Disorders Linked with Abnormal Activation of FGFR3
In force
 · Medium confidence
In forceMedium confidence
US 9,290,792Method for Measuring Calcineurin Activity
In force
 · High confidence
In forceHigh confidence
US 9,198,949Method and Pharmaceutical Composition for Use in the Treatment of Cancer
In force
 · High confidence
In forceHigh confidence
US 10,034,868Methods for the Prevention and the Treatment of Rapidly Progressive Glomerulonephritis
In force
 · High confidence
In forceHigh confidence
US D899,694Locomotion training device for infants
In force
 · USPTO record
In forceUSPTO record
US 10,812,240Determination Of Frequency Resources For Wireless Communication Devices
In force
 · High confidence
In forceHigh confidence
US 11,426,430Method for Generating T Cells Progenitors
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 10: 173 patents in force now held by others · 75 lapsed for an unpaid fee · 6 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

4 pending · 116 abandoned · 7 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited